Kecia Steelman, Ulta’s chief operating officer who added president to her title in September, will continue overseeing work to combat organized retail theft, which impacted the company’s gross profit in the 2023 first fiscal quarter and continued to be a headwind in the second quarter, reported on 24 August. The retailer has installed new fixtures to combat the threat, placing fragrances and other high-priced items behind lock and key in more than 50% of its stores, with plans to have them installed in 70% of stores by year-end.
Cosmetics News: Ulta COO Adds Feather To Her Cap; Inter Parfums Q3; Perfect’s Hairstyling Virtual Try-On; More
Battling organized retail crime, which Ulta has managed to curtail with new security fixtures in its stores, is just one of numerous areas overseen by Kecia Steelman, Ulta’s chief operating officer who added president to her title in September. More cosmetics news.
More from Leadership
• By
A round-up of the latest industry moves in Europe: Pharma Deutschland elects board of new Brussels operation; MHRA's new CEO gets to work; Futura names non-executive director.
• By
The General Services Administration’s updated list of “assets identified for accelerated disposition” does not include any buildings at the agency’s headquarters in White Oak, MD after its original list of “non-core” government properties for disposal had more than half the buildings on campus.
• By
Round up of the latest appointments: PAGB names vice presidents; Activ'Inside gets first US head; EMA elects management board chair.
• By
Stakeholders are pleading for newly confirmed FDA Commissioner Martin Makary to stand up for the agency's high scientific standards and staff as he begins his term.
More from HBW Insight
• By
A round-up of the latest industry moves in Europe: Pharma Deutschland elects board of new Brussels operation; MHRA's new CEO gets to work; Futura names non-executive director.
• By
“If this doesn’t get reauthorized, look at the number of the ingredients out there, the number of products, what would happen all those products out there for the consumer, on that shelf, in the drugstore or someplace?” says Rep. Bob Latta during House hearing.
• By
Energy and Commerce Health Subcommittee Democrats focus on criticizing HHS Secretary Kennedy’s RIF announcement, including 3,500 FDA jobs among cuts across HHS agencies. “If we reauthorize it, will it continue?” Texas representative Lizzie Fletcher asks of OMUFA.